[go: up one dir, main page]

AR066696A1 - Sales de picotamida. composiciones farmaceuticas. - Google Patents

Sales de picotamida. composiciones farmaceuticas.

Info

Publication number
AR066696A1
AR066696A1 ARP080102122A ARP080102122A AR066696A1 AR 066696 A1 AR066696 A1 AR 066696A1 AR P080102122 A ARP080102122 A AR P080102122A AR P080102122 A ARP080102122 A AR P080102122A AR 066696 A1 AR066696 A1 AR 066696A1
Authority
AR
Argentina
Prior art keywords
picotamide
salts
pharmaceutical compositions
acid
compositions containing
Prior art date
Application number
ARP080102122A
Other languages
English (en)
Original Assignee
Dybly Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dybly Ag filed Critical Dybly Ag
Publication of AR066696A1 publication Critical patent/AR066696A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Composiciones farmacéuticas que contienen sales de picotamida y a un método de tratamiento de enfermedades cardiovasculares y otras enfermedades relacionadas utilizando sales de picotamida. Reivindicacion 1: Una sal de adicion de ácido de picotamida con un ácido fuerte.
ARP080102122A 2007-05-21 2008-05-19 Sales de picotamida. composiciones farmaceuticas. AR066696A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07108522 2007-05-21

Publications (1)

Publication Number Publication Date
AR066696A1 true AR066696A1 (es) 2009-09-09

Family

ID=38658581

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080102122A AR066696A1 (es) 2007-05-21 2008-05-19 Sales de picotamida. composiciones farmaceuticas.

Country Status (4)

Country Link
US (1) US20080293772A1 (es)
AR (1) AR066696A1 (es)
TW (1) TW200900393A (es)
WO (1) WO2008142106A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018104235A1 (en) 2016-12-09 2018-06-14 Curatis Ag Picotamide for the use in migraine
WO2019228636A1 (en) 2018-05-31 2019-12-05 Curatis Ag Dosage regimen for picotamide for the use in migraine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1016005B (it) * 1970-07-01 1977-05-30 Manetti & Roberts Italo Brit Picolilamidi dell acido 4 idrossi isoftalico e suoi derivati e relativo procedimento di prepara zione
US3973026A (en) * 1975-02-05 1976-08-03 Societa Italo-Britannica L. Manetti-H. Roberts & C. Inhibitor of blood plate aggregation
IT1143942B (it) * 1980-04-23 1986-10-29 Manetti & Roberts Italo Brit Picolilammide idrata di acido isoftalico ad azione antiaggregante piastrinica antitrombinica ed anticoagulante e procedimento per la sua preparazione

Also Published As

Publication number Publication date
US20080293772A1 (en) 2008-11-27
TW200900393A (en) 2009-01-01
WO2008142106A1 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
CR20120167A (es) Conjugados de niacina y ácidos grasos y sus usos
AR121611A2 (es) Inhibidores de glucosilceramida sintasa
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
CY1120888T1 (el) Διαδερμικες φαρμακευτικες συνθεσεις περιλαμβανοντας ενεργους παραγοντες
AR109605A2 (es) Método para tratar enfermedades vasculares periféricas, composición y utilización
EA201001577A1 (ru) Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения
ECSP12012208A (es) Formulaciones orales y sales lipofílicas de metilnaltrexona
ECSP12012097A (es) Derivados de fumarato de ácido graso y sus usos
BR112012008317A2 (pt) produto de liberação sustentada compreendendo uma combinação de uma amina não-opioide e uma droga anti-inflamatória não-esteroidal
CR20110016A (es) Compuestos quimicos 251
AR084433A1 (es) Inhibidores de la faah y composiciones farmaceuticas que los contienen
MX366925B (es) Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
EP2349279A4 (en) MODIFIERS OF ALDEHYDE DEHYDROGENASE AND METHODS OF USE THEREOF
CR11648A (es) Composicion que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes acidas
CL2014000297A1 (es) Uso de un inhibidores de corrientes "funny" (if) o una de sus sales para utilizar en un metodo de tratamiento y prevencion de la insuficiencia cardiaca en felinos .
CL2011002194A1 (es) Formulacion que comprende anticuerpo en un regulador de histidina-arginina ph 4.5 a 6.5; articulo de manufactura que comprende dicha formulacion; metodo para estabilizar un anticuerpo en una formulacion farmaceutica acuosa.
MX2019002774A (es) Inhibidores de la recirculacion de acidos biliares para el tratamiento de hipercolemia y enfermedad hepatica colestasica.
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
CR9462A (es) Inhibidores de la dipeptidil peptidasa-iv
CL2008003284A1 (es) Compuestos derivados de 4-bencilamino-1-carboxiacil-piridina, inhibidores cetp; composicion farmaceutica que los comprende; combinacion farmaceutica; y uso en el tratamiento de enfermedades metabolicas, ateroesclerosis y cardiovasculares, entre otras.
CL2012001597A1 (es) Formulacion farmaceutica que comprende ranolazina y dronedarona o una sal de esta, y un portador farmaceuticamente aceptable; util para tratar fibrilacion auricular.
CY1117962T1 (el) Υδροχλωρικο αλας 4-[2-[[5-μεθυλο-1-(2- ναφθαλενυλο)-1η- πυραζολ-3-υλ]οξυ]αιθυλο] μορφολινης
UY32423A (es) Derivados de azaspiranil-alquilcarbamatos de 5 eslabones, su preparacion y su aplicacion en terapeutica
CY1116168T1 (el) Συγκρυσταλλοι και αλατα αναστολεων toy ccr3
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.

Legal Events

Date Code Title Description
FB Suspension of granting procedure